Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?

Journal of the American College of Cardiology

Volumn 68, Issue 9, 2016, Pages 949-966

  Arbustini, Eloisa ^a   Favalli, Valentina ^a   Narula, Nupoor ^a,b   Serio, Alessandra ^a   Grasso, Maurizia ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

congenital heart disease; genetic counseling; genetic testing; heart ventricles; mitochondrial myopathies; myocardium

Indexed keywords

MITOCHONDRIAL DNA;

CARDIOVASCULAR MAGNETIC RESONANCE; CHROMOSOME DISORDER; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; FAMILY; GENETIC ASSOCIATION; GENETIC SCREENING; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HUMAN; MONOGENIC DISORDER; PREVALENCE; PRIORITY JOURNAL; REVIEW; VENTRICULAR NONCOMPACTION; ATHLETE; CARDIOMYOPATHIES; DIFFERENTIAL DIAGNOSIS; GENETICS; HEART LEFT VENTRICLE FUNCTION; ISOLATED NONCOMPACTION OF THE VENTRICULAR MYOCARDIUM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ATHLETES; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; GENETIC TESTING; HUMANS; ISOLATED NONCOMPACTION OF THE VENTRICULAR MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 84995877245     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.05.096     Document Type: Review

References (118)

1. 1 Jenni, R., Oechslin, E.N., van der Loo, B., Isolated ventricular non-compaction of the myocardium in adults. Heart 93 (2007), 11–15.
2. 2 Ulusoy, R.E., Kucukarslan, N., Kirilmaz, A., et al. Noncompaction of ventricular myocardium involving both ventricles. Eur J Echocardiogr 7 (2006), 457–460.
3. 3 Ranganathan, A., Ganesan, G., Sangareddi, V., et al. Isolated noncompaction of right ventricle—a case report. Echocardiography 29 (2012), E169–E172.
4. 4 Maron, B.J., Towbin, J.A., Thiene, G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006), 1807–1816.
5. 5 Elliott, P., Andersson, B., Arbustini, E., et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29 (2008), 270–276.
6. 6 Arbustini, E., Narula, N., Dec, G.W., et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol 62 (2013), 2046–2072.
7. 7 Arbustini, E., Weidemann, F., Hall, J.L., Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?. J Am Coll Cardiol 64 (2014), 1840–1850.
8. 8 Samsa, L.A., Yang, B., Liu, J., Embryonic cardiac chamber maturation: trabeculation, conduction and cardiomyocyte proliferation. Am J Med Genet C Semin Med Genet 163C (2013), 157–168.
9. 9 Moore, B., Prasad Dasi, L., Quantifying left ventricular trabeculae function—application of image-based fractal analysis. Physiol Rep, 1, 2013, e00068.
10. 10 Ferreira, C., Thompson, R., Vernon, H., Barth syndrome. Pagon, R.A., Adam, M.P., Ardinger, H.H., et al. (eds.) GeneReviews, 1993, University of Washington, Seattle, Seattle, WA Available at: http://www.ncbi.nlm.nih.gov/books/NBK247162/ Accessed June 16, 2016.
11. 11 Stähli, B.E., Gebhard, C., Biaggi, P., et al. Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol 167 (2013), 2477–2481.
12. 12 Hofer, M., Stöllberger, C., Finsterer, J., Acquired noncompaction associated with myopathy. Int J Cardiol 121 (2007), 296–297.
13. 13 Markovic, N.S., Dimkovic, N., Damjanovic, T., et al. Isolated ventricular noncompaction in patients with chronic renal failure. Clin Nephrol 70 (2008), 72–76.
14. 14 Piga, A., Longo, F., Musallam, K.M., et al. Left ventricular noncompaction in patients with β-thalassemia: uncovering a previously unrecognized abnormality. Am J Hematol 87 (2012), 1079–1083.
15. 15 Gati, S., Chandra, N., Bennett, R.L., et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?. Heart 99 (2013), 401–408.
16. 16 Gati, S., Papadakis, M., Van Niekerk, N., et al. Increased left ventricular trabeculation in individuals with sickle cell anaemia: physiology or pathology?. Int J Cardiol 168 (2013), 1658–1660.
17. 17 Gati, S., Papadakis, M., Papamichael, N.D., et al. Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation 130 (2014), 475–483.
18. 18 D'Ascenzi, F., Pelliccia, A., Natali, B.M., et al. Exercise-induced left-ventricular hypertrabeculation in athlete's heart. Int J Cardiol 181 (2015), 320–322.
19. 19 Caselli, S., Attenhofer Jost, C.H., Jenni, R., et al. Left ventricular noncompaction diagnosis and management relevant to pre-participation screening of athletes. Am J Cardiol 116 (2015), 801–808.
20. 20 Zemrak, F., Ahlman, M.A., Captur, G., et al. The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. J Am Coll Cardiol 64 (2014), 1971–1980.
21. 21 Poscolieri, B., Bianco, M., Vessella, T., et al. Identification of benign form of ventricular non-compaction in competitive athletes by multiparametric evaluation. Int J Cardiol 176 (2014), 1134–1136.
22. 22 Stöllberger, C., Gerecke, B., Engberding, R., et al. Interobserver agreement of the echocardiographic diagnosis of LV hypertrabeculation/noncompaction. J Am Coll Cardiol Img 8 (2015), 1252–1257.
23. 23 Gati, S., Rajani, R., Carr-White, G.S., et al. Adult left ventricular noncompaction: reappraisal of current diagnostic imaging modalities. J Am Coll Cardiol Img 7 (2014), 1266–1275.
24. 24 Captur, G., Syrris, P., Obianyo, C., et al. Formation and malformation of cardiac trabeculae: biological basis, clinical significance, and special yield of magnetic resonance imaging in assessment. Can J Cardiol 31 (2015), 1325–1337.
25. 25 Petersen, S.E., Selvanayagam, J.B., Wiesmann, F., et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46 (2005), 101–105.
26. 26 Jenni, R., Oechslin, E., Schneider, J., et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86 (2001), 666–671.
27. 27 Jacquier, A., Thuny, F., Jop, B., et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 31 (2010), 1098–1104.
28. 28 André, F., Burger, A., Loßnitzer, D., et al. Reference values for left and right ventricular trabeculation and non-compacted myocardium. Int J Cardiol 185 (2015), 240–247.
29. 29 Dawson, D.K., Maceira, A.M., Raj, V.J., et al. Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance. Circ Cardiovasc Imaging 4 (2011), 139–146.
30. 30 Grothoff, M., Pachowsky, M., Hoffmann, J., et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol 22 (2012), 2699–2709.
31. 31 Marchal, P., Lairez, O., Cognet, T., et al. Relationship between left ventricular sphericity and trabeculation indexes in patients with dilated cardiomyopathy: a cardiac magnetic resonance study. Eur Heart J Cardiovasc Imaging 14 (2013), 914–920.
32. 32 Sidhu, M.S., Uthamalingam, S., Ahmed, W., et al. Defining left ventricular noncompaction using cardiac computed tomography. J Thorac Imaging 29 (2014), 60–66.
33. 33 Kozor, R., Callaghan, F., Tchan, M., et al. A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease. J Cardiovasc Magn Reson, 17, 2015, 22.
34. 34 Azevedo, O., Gaspar, P., Sá Miranda, C., et al. Left ventricular noncompaction in a patient with Fabry disease: overdiagnosis, morphological manifestation of Fabry disease or two unrelated rare conditions in the same patient?. Cardiology 119 (2011), 155–159.
35. 35 Stöllberger, C., Finsterer, J., Voigtländer, T., et al. Is left ventricular hypertrabeculation/noncompaction a cardiac manifestation of Fabry's disease?. Z Kardiol 92 (2003), 966–969.
36. 36 Van Der Starre, P., Deuse, T., Pritts, C., et al. Late profound muscle weakness following heart transplantation due to Danon disease. Muscle Nerve 47 (2013), 135–137.
37. 37 Niemann, M., Liu, D., Hu, K., et al. Echocardiographic quantification of regional deformation helps to distinguish isolated left ventricular non-compaction from dilated cardiomyopathy. Eur J Heart Fail 14 (2012), 155–161.
38. 38 Ari, M.E., Cetin, I.I., Kocabas, A., et al. Decreased deformation in asymptomatic children with isolated left ventricular non-compaction and normal ejection fraction. Pediatr Cardiol 37 (2015), 201–207.
39. 39 Bleyl, S.B., Mumford, B.R., Thompson, V., et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 61 (1997), 868–872.
40. 40 Chen, R., Tsuji, T., Ichida, F., et al. Noncompaction study collaborators. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol Genet Metab 77 (2002), 319–325.
41. 41 Waldmüller, S., Schroeder, C., Sturm, M., et al. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies. Mol Cell Probes 29 (2015), 308–314.
42. 42 Klaassen, S., Probst, S., Oechslin, E., et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117 (2008), 2893–2901.
43. 43 Girolami, F., Iascone, M., Tomberli, B., et al. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study. Circ Cardiovasc Genet 7 (2014), 741–750.
44. 44 Bagnall, R.D., Molloy, L.K., Kalman, J.M., et al. Exome sequencing identifies a mutation in the ACTN2 gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden death. BMC Med Genet, 15, 2014, 99.
45. 45 Egan, K.R., Ralphe, J.C., Weinhaus, L., et al. Just sinus bradycardia or something more serious?. Case Rep Pediatr, 2013, 2013, 736164.
46. 46 Finsterer, J., Stöllberger, C., Wegmann, R., et al. Acquired left ventricular hypertrabeculation/noncompaction in myotonic dystrophy type 1. Int J Cardiol 137 (2009), 310–313.
47. 47 Ichida, F., Tsubata, S., Bowles, K.R., et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103 (2001), 1256–1263.
48. 48 Milano, A., Vermeer, A.M., Lodder, E.M., et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J Am Coll Cardiol 64 (2014), 745–756.
49. 49 Vatta, M., Mohapatra, B., Jimenez, S., et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42 (2003), 2014–2027.
50. 50 Liu, Z., Shan, H., Huang, J., et al. A novel lamin A/C gene missense mutation (445 V > E) in immunoglobulin-like fold associated with left ventricular non-compaction. Europace 18 (2016), 617–622.
51. 51 Rankin, J., Auer-Grumbach, M., Bagg, W., et al. Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C. Am J Med Genet A 146A (2008), 1530–1542.
52. 52 Luxán, G., Casanova, J.C., Martínez-Poveda, B., et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med 19 (2013), 193–201.
53. 53 Probst, S., Oechslin, E., Schuler, P., et al. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet 4 (2011), 367–374.
54. 54 Schaefer, E., Helms, P., Marcellin, L., et al. Next-generation sequencing (NGS) as a fast molecular diagnosis tool for left ventricular noncompaction in an infant with compound mutations in the MYBPC3 gene. Eur J Med Genet 57 (2014), 129–132.
55. 55 Dellefave, L.M., Pytel, P., Mewborn, S., et al. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circ Cardiovasc Genet 2 (2009), 442–449.
56. 56 Hoedemaekers, Y.M., Caliskan, K., Majoor-Krakauer, D., et al. Cardiac β-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J 28 (2007), 2732–2737.
57. 57 Budde, B.S., Binner, P., Waldmüller, S., et al. Noncompaction of the ventricular myocardium is associated with a de novo mutation in the β-myosin heavy chain gene. PLoS One, 2, 2007, e1362.
58. 58 Muhammad, E., Levitas, A., Singh, S.R., et al. PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction. Hum Mol Genet 24 (2015), 7227–7240.
59. 59 Ramond, F., Janin, A., Filippo, S.D., et al. Homozygous PKP2 deletion associated with neonatal left ventricule non compaction. Clin Genet, 2016 Mar 31 [E-pub ahead of print].
60. 60 Arndt, A.K., Schafer, S., Drenckhahn, J.D., et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet 93 (2013), 67–77.
61. 61 Campbell, M.J., Czosek, R.J., Hinton, R.B., et al. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest. Am J Med Genet A 167A (2015), 2197–2200.
62. 62 Ohno, S., Omura, M., Kawamura, M., et al. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Europace 16 (2014), 1646–1654.
63. 63 Shan, L., Makita, N., Xing, Y., et al. SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia. Mol Genet Metab 93 (2008), 468–474.
64. 64 Luedde, M., Ehlermann, P., Weichenhan, D., et al. Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovasc Res 86 (2010), 452–460.
65. 65 Chang, B., Nishizawa, T., Furutani, M., et al. Noncompaction study collaborators. Identification of a novel TPM1 mutation in a family with left ventricular noncompaction and sudden death. Mol Genet Metab 102 (2011), 200–206.
66. 66 Yilmaz, S., Gokben, S., Serdaroglu, G., et al. The expanding phenotypic spectrum of ARFGEF2 gene mutation: cardiomyopathy and movement disorder. Brain Dev 38 (2015), 124–127.
67. 67 Davey, K.M., Parboosingh, J.S., McLeod, D.R., et al. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J Med Genet 43 (2006), 385–393.
68. 68 Prada, C.E., Jefferies, J.L., Grenier, M.A., et al. Malonyl coenzyme A decarboxylase deficiency: early dietary restriction and time course of cardiomyopathy. Pediatrics 130 (2012), e456–e460.
69. 69 Profitlich, L.E., Kirmse, B., Wasserstein, M.P., et al. High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria. Mol Genet Metab 98 (2009), 344–348.
70. 70 Bainbridge, M.N., Davis, E.E., Choi, W.Y., et al. Loss of function mutations in NNT are associated with left ventricular noncompaction. Circ Cardiovasc Genet 8 (2015), 544–552.
71. 71 Martinez, H.R., Belmont, J.W., Craigen, W.J., et al. Left ventricular noncompaction in Sotos syndrome. Am J Med Genet A 155A (2011), 1115–1118.
72. 72 Facher, J.J., Regier, E.J., Jacobs, G.H., et al. Cardiomyopathy in Coffin-Lowry syndrome. Am J Med Genet A 128A (2004), 176–178.
73. 73 Chang, B., Gorbea, C., Lezin, G., et al. 14-3-3ε Gene variants in a Japanese patient with left ventricular noncompaction and hypoplasia of the corpus callosum. Gene 515 (2013), 173–180.
74. 74 Opdal, S.H., Vege, A., Egeland, T., et al. Possible role of mtDNA mutations in sudden infant death. Pediatr Neurol 27 (2002), 23–29.
75. 75 Tang, S., Batra, A., Zhang, Y., et al. Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion 10 (2010), 350–357.
76. 76 Zarrouk Mahjoub, S., Mehri, S., Ourda, F., et al. Transition m.3308T>C in the ND1 gene is associated with left ventricular hypertrabeculation/noncompaction. Cardiology 118 (2011), 153–158.
77. 77 Liu, S., Bai, Y., Huang, J., et al. Do mitochondria contribute to left ventricular non-compaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy. Mol Genet Metab 109 (2013), 100–106.
78. 78 Digilio, M.C., Bernardini, L., Gagliardi, M.G., et al. Syndromic non-compaction of the left ventricle: associated chromosomal anomalies. Clin Genet 84 (2013), 362–367.
79. 79 Bahado-Singh, R.O., Zaffra, R., Albayarak, S., et al. Epigenetic markers for newborn congenital heart defect (CHD). J Matern Fetal Neonatal Med 29 (2016), 1881–1887.
80. 80 Charron, P., Arad, M., Arbustini, E., et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31 (2010), 2715–2726.
81. 81 Hoedemaekers, Y.M., Caliskan, K., Michels, M., et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 3 (2010), 232–239.
82. 82 Caliskan, K., Michels, M., Geleijense, M.L., et al. Frequency of asymptomatic disease among family members with noncompaction cardiomyopathy. Am J Cardiol 110 (2012), 1512–1517.
83. 83 Marziliano, N., Mannarino, S., Nespoli, L., et al. Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A 143A (2007), 907–915.
84. 84 Sasse-Klaassen, S., Probst, S., Gerull, B., et al. Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15. Circulation 109 (2004), 2720–2723.
85. 85 Monserrat, L., Hermida-Prieto, M., Fernandez, X., et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 28 (2007), 1953–1961.
86. 86 Greenway, S.C., McLeod, R., Hume, S., et al. Exome sequencing identifies a novel variant in ACTC1 associated with familial atrial septal defect. Can J Cardiol 30 (2014), 181–187.
87. 87 Haberer, K., Buffo-Sequeira, I., Chudley, A.E., et al. A case of an infant with compound heterozygous mutations for hypertrophic cardiomyopathy producing a phenotype of left ventricular noncompaction. Can J Cardiol 30 (2014), 1249.e1–1249.e3.
88. 88 Hermida-Prieto, M., Monserrat, L., Castro-Beiras, A., et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 94 (2004), 50–54.
89. 89 Priori, S.G., Blomström-Lundqvist, C., Mazzanti, A., et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 36 (2015), 2793–2867.
90. 90 van Rijsingen, I.A., Arbustini, E., Elliott, P.M., et al. Risk factors for malignant ventricular arrhythmias in Lamin A/C mutation carriers: a European cohort study. J Am Coll Cardiol 59 (2012), 493–500.
91. 91 Theis, J.L., Bos, J.M., Bartleson, V.B., et al. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun 351 (2006), 896–902.
92. 92 Lopez-Ayala, J.M., Ortiz-Genga, M., Gomez-Milanes, I., et al. A mutation in the Z-line Cypher/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy. Clin Genet 88 (2015), 172–176.
93. 93 Zhou, Q., Chu, P.H., Huang, C., et al. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol 155 (2001), 605–612.
94. 94 Levitas, A., Konstantino, Y., Muhammad, E., et al. D117N in Cypher/ZASP may not be a causative mutation for dilated cardiomyopathy and ventricular arrhythmias. Eur J Hum Genet 24 (2016), 666–671.
95. 95 Xi, Y., Ai, T., De Lange, E., et al. Loss of function of hNav1.5 by a ZASP1 mutation associated with intraventricular conduction disturbances in left ventricular noncompaction. Circ Arrhythm Electrophysiol 5 (2012), 1017–1026.
96. 96 Stöllberger, C., Finsterer, J., Blazek, G., Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 90 (2002), 899–902.
97. 97 Statile, C.J., Taylor, M.D., Mazur, W., et al. Left ventricular noncompaction in Duchenne muscular dystrophy. J Cardiovasc Magn Reson, 15, 2013, 67.
98. 98 Kimura, K., Takenaka, K., Ebihara, A., et al. Prognostic impact of left ventricular noncompaction in patients with Duchenne/Becker muscular dystrophy—prospective multicenter cohort study. Int J Cardiol 168 (2013), 1900–1904.
99. 99 Captur, G., Wilson, R., Bennett, M.F., et al. Morphogenesis of myocardial trabeculae in the mouse embryo. J Anat 229 (2016), 314–325.
100. 100 Martinez, H.R., Niu, M.C., Sutton, V.R., et al. Coffin-Lowry syndrome and left ventricular noncompaction cardiomyopathy with a restrictive pattern. Am J Med Genet A 155A (2011), 3030–3034.
101. 101 MITOMAP: a human mitochondrial genome database. Available at: http://www.mitomap.org/MITOMAP. Accessed June 17, 2016.
102. 102 Fukino, K., Ishiwata, J., Shinohara, H., et al. Noncompaction of the ventricular myocardium and polycystic kidney disease: a case report. Am J Kidney Dis 67 (2016), 945–948.
103. 103 Katukuri, N.P., Finger, J., Vaitkevicius, P., et al. Association of left ventricular noncompaction with polycystic kidney disease as shown by cardiac magnetic resonance imaging. Tex Heart Inst J 41 (2014), 449–452.
104. 104 Briongos-Figuero, S., Ruiz-Rejón, F., Jiménez-Nacher, J.J., et al. Familial form of noncompaction cardiomyopathy associated with polycystic kidney disease. Rev Esp Cardiol 63 (2010), 488–489.
105. 105 Moon, J.Y., Chung, N., Seo, H.S., et al. Noncompaction of the ventricular myocardium combined with polycystic kidney disease. Heart Vessels 21 (2006), 195–198.
106. 106 Captur, G., Zemrak, F., Muthurangu, V., et al. Fractal analysis of myocardial trabeculations in 2547 study participants: Multi-Ethnic Study of Atherosclerosis. Radiology 277 (2015), 707–715.
107. 107 Jefferies, J.L., Wilkinson, J.D., Sleeper, L.A., et al. Pediatric Cardiomyopathy Registry Investigators. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the Pediatric Cardiomyopathy Registry. J Card Fail 21 (2015), 877–884.
108. 108 Miyake, C.Y., Kim, J.J., Arrhythmias in left ventricular noncompaction. Card Electrophysiol Clin 7 (2015), 319–330.
109. 109 Hussein, A., Karimianpour, A., Collier, P., et al. Isolated noncompaction of the left ventricle in adults. J Am Coll Cardiol 66 (2015), 578–585.
110. 110 Hershberger, R.E., Lindenfeld, J., Mestroni, L., et al. Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail 15 (2009), 83–97.
111. 111 Ganame, J., Left ventricular non-compaction: from recognition to treatment. Curr Pharm Des 21 (2015), 484–490.
112. 112 Maron, B.J., Udelson, J.E., Bonow, R.O., et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66 (2015), 2362–2371.
113. 113 Maron, B.J., Ackerman, M.J., Nishimura, R.A., et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 45 (2005), 1340–1345.
114. 114 Arbustini, E., Narula, N., Tavazzi, L., et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol 64 (2014), 304–318.
115. 115 Biomeris srl. MOGE(S). Available at: http://moges.biomeris.com/moges.html. Accessed June 17, 2016.
116. 116 Agarwal, A., Yousefzai, R., Jan, M.F., et al. Clinical application of WHF-MOGE(S) classification for hypertrophic cardiomyopathy. Glob Heart 10 (2015), 209–219.
117. 117 Hazebroek, M.R., Moors, S., Dennert, R., et al. Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification. J Am Coll Cardiol 66 (2015), 1313–1323.
118. 118 Sibbing, D., Pfeufer, A., Perisic, T., et al. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J 32 (2011), 1121–1133.